A novel immunomodulating agent--leflunomide inhibits experimental autoimmune diabetes in mice.
Stosić-Grujicić
S
S
Institute for Biological Research Sinisa Stankovic, University of Belgrade, Yugoslavia.
Dimitrijević
M
M
Bartlett
R R
RR
D000818:Animals; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism*; D003921:Diabetes Mellitus, Experimental / Q000097:blood / Q000517:prevention & control*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000517:prevention & control*; D006943:Hyperglycemia / Q000517:prevention & control; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007555:Isoxazoles / Q000494:pharmacology*; D000077339:Leflunomide; D008297:Male; D051379:Mice; D008808:Mice, Inbred CBA; D013997:Time Factors
D001786:Blood Glucose; D007166:Immunosuppressive Agents; D007555:Isoxazoles; D000077339:Leflunomide